Back
ANI Pharmaceuticals Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
41
ANIP
ANI Pharmaceuticals
Last Price:
58.94
Seasonality Move:
5.08%
Buy
64
PLX
Protalix BioTherapeutics
Last Price:
1.41
Seasonality Move:
72.04%
Sell
41
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $59.87. The Score for ANIP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.24. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $59.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing selling pressure, which indicates risk of future bearish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -344189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.1 - 60.3) | Buy |
| Bollinger Bands (100): | (57.75 - 62.97) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 57.9 | Buy |
| Chaikin Money Flow: | -197064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.23) | Buy |
| Bollinger Bands (100): | (0.99 - 1.17) | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.33 | Buy |
| 20-day SMA: | 59.07 | Buy |
| 50-day SMA: | 58.58 | Buy |
| 200-day SMA: | 62.13 | Sell |
| 8-day EMA: | 59.85 | Buy |
| 20-day EMA: | 59.13 | Buy |
| 50-day EMA: | 59.2 | Buy |
| 200-day EMA: | 59.91 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.24 | Buy |
| 20-day SMA: | 1.16 | Buy |
| 50-day SMA: | 1.1 | Buy |
| 200-day SMA: | 1.18 | Buy |
| 8-day EMA: | 1.23 | Buy |
| 20-day EMA: | 1.18 | Buy |
| 50-day EMA: | 1.12 | Buy |
| 200-day EMA: | 1.21 | Buy |
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ANI Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||